News

Azitra holds $3.8M cash against $3.0M Q3 loss as ATR-04 advances

Image
Azitra holds $3.8M cash against $3.0M Q3 loss as ATR-04 advances

BRANFORD -- November 12, 2026 -- Azitra (NYSE American: AZTR) ended the quarter on September 30, 2026 with $3.8 million in cash and cash equivalents, about 1.3 times its $3.0 million net loss for the quarter. The company says investors in its March 2026 private placement can put in a further $5.25 million to $10.5 million once it reports first-in-human results for its ATR-COSF cosmetic ingredient, which it expects by year-end 2026.

Azitra's quarterly net loss widens 7% while administrative costs stay flat

Net loss was $3.0 million, up from $2.8 million in the third quarter of 2025, an increase of about 7% by FairsOnline's calculation. Research and development expenses rose to $1.3 million from $1.2 million, about 8%. General and administrative expenses were $1.6 million in both periods. Together, R&D and G&A come to $2.9 million, most of the quarter's loss.

Mindmatrix pairs GTMOS with Bodine and Co. partner services

Image
Mindmatrix pairs GTMOS with Bodine and Co. partner services

PITTSBURGH – November 13, 2026 -- Mindmatrix, maker of the GTMOS go-to-market operating system, has partnered with San Francisco-based consultancy Bodine and Co. to combine the software with Bodine's Partner Experience (PX) services, the companies announced on Nov. 12, 2026. The announcement comes no more than six weeks after Mindmatrix introduced GTMOS in October 2026.

The offer pairs a software vendor headquartered in Pittsburgh, which says it serves enterprise and midmarket customers in more than 25 countries, with a consultancy that sells partner program design and optimization. Bodine and Co. was founded by Kerry Bodine, author of the book Outside In. The companies say the combination is meant to increase the number of partners that contribute to pipeline, revenue and customer success.

Essity invests SEK 850m in Lilla Edet tissue machine for Tork

STOCKHOLM — November 13, 2026 -- Essity is investing about SEK 850 million in a new tissue machine at its Lilla Edet plant in Sweden, with spending spread over three years. The machine is due to start in the fourth quarter of 2028, about two years after this announcement, and will have 50% more production capacity than the existing machine, the company says.

Spread evenly over the three years, the outlay works out to roughly SEK 283 million a year by FairsOnline's calculation. Against the roughly 400 people employed at the site, it equals about SEK 2.1 million per current employee.

The machine can run on virgin and recycled fiber. It can produce paper hand towels, toilet paper, napkins and wiping products, which Essity says gives it more production flexibility than the existing machine.

UPTUNITY Aneurysm AI wins FDA 510(k) clearance for Bracco

Image
UPTUNITY Aneurysm AI wins FDA 510(k) clearance for Bracco

MILAN — November 13, 2026 -- Bracco and Avicenna.AI have received U.S. FDA 510(k) clearance for UPTUNITY | Aneurysm, AI software that flags suspected brain aneurysms larger than 3 mm on head CTA scans. The clearance comes about eight months after the two companies announced their partnership in March 2026.

It is the first product in Bracco's new UPTUNITY portfolio of clinical decision support tools, and the first of the company's AI offerings named in the announcement to interpret images. The existing AiMIFY, developed with Subtle Medical, enhances contrast in brain MRI.

ADHD accommodations fail to improve behavior in 255-child FIU trial

Image
ADHD accommodations fail to improve behavior in 255-child FIU trial

MIAMI — November 13, 2026 -- None of the four ADHD accommodations tested in a randomized clinical trial (extended time, frequent breaks, standing at a desk and a low-distraction workspace) significantly improved classroom behavior or quiz scores, according to a study in JAMA Pediatrics. In the same trial, behavioral interventions cut classroom rule violations by 37% and stimulant medication by 61%, Florida International University (FIU) reports.

Stimulant medication cut rule violations by 61% and raised completed assignments by 22%

Researchers at FIU's Center for Children and Families ran the trial through the university's Summer Treatment Program. It enrolled 255 children in kindergarten through sixth grade who began participating between 2022 and 2025. Of those, 235 finished the study, a completion rate of about 92% by FairsOnline's calculation, which leaves 20 children who did not complete it.

Enjay Converters gains second plant through New Method deal

Image
Enjay Converters gains second plant through New Method deal

Cobourg — November 13, 2026 -- Enjay Converters, a Cobourg, Ontario, maker of food-contact packaging, has gained a second manufacturing site through a transaction with Springfield, Ohio-based New Method. The Ohio facility covers 97,000 sq ft of production and office space, against 90,000 sq ft of manufacturing and office space at Enjay's Ontario plant. Together the two sites total 187,000 sq ft, about double Enjay's current manufacturing footprint by FairsOnline's calculation.

The companies did not disclose financial terms or the deal structure. Enjay names Champlain Financial Corporation of Montreal as its financial partner in completing the transaction.

Pharma Deutschland says Standortklausel funding is still unbudgeted

BERLIN — – November 13, 2026 -- Germany's budget deliberations have ended without funding for the Standortklausel (location clause), according to industry association Pharma Deutschland. The budget contains only an unbudgeted line item, which the association calls an empty title.

The clause is meant to give the pharmaceutical industry partial relief from additional burdens under the Beitragssatzstabilisierungsgesetz, the association says. Managing Director Dorothee Brakmann says the association was assured in recent days that financing outside statutory health insurance (GKV) had been agreed in principle. No funding has followed. She puts responsibility on the Federal Minister for Economic Affairs, whom the association describes as hesitant, and on the Chancellor.

Old Republic raises 2026 dividend 8.6% to $1.26 a share

CHICAGO — November 13, 2026 -- Old Republic International Corporation (NYSE: ORI) declared a regular quarterly dividend of 31.5 cents per share, bringing its 2026 dividend to $1.26 per share, up 8.6% from $1.16 paid in 2025. The increase of $0.10 per share is the 45th consecutive annual rise in the insurer's regular dividend, the company said.

Old Republic's 2026 total equals four quarterly payments of 31.5 cents

By our calculation, $1.26 divided by four quarters is exactly 31.5 cents. If the total consists only of regular quarterly payments, the first three 2026 payments also averaged 31.5 cents. The 2025 total of $1.16 works out to an average of 29 cents per quarter, so the new quarterly rate is about 8.6% above that average.

For a holder of 1,000 shares, the fourth-quarter payment amounts to $315. Dividends for the full year come to $1,260, against $1,160 in 2025, a difference of $100.

Cohen & Steers to change three Realty Majors indexes on Nov 20

NEW YORK – November 13, 2026 -- Cohen & Steers (NYSE: CNS) will change three of its realty indexes, the Realty Majors Portfolio Index (RMP), the Global Realty Majors Portfolio Index (GRM) and the International Realty Majors Portfolio Index (IRP), effective at the close of business on November 20, 2026. The company announced the changes on November 13, 2026, which gives users seven calendar days of notice.

The company did not say which securities are being added or removed.

All three are free-float adjusted, modified market capitalization-weighted total return indexes of selected real estate equity securities. The Chicago Mercantile Exchange quotes them intraday in real time. Standard & Poor's calculates all index weightings independently.

Infotech tells CIOs to verify Microsoft 365 outage recovery first

Image
Infotech tells CIOs to verify Microsoft 365 outage recovery first

ARLINGTON — November 13, 2026 -- Infotech, a research and advisory firm, is telling CIOs not to declare normal operations restored after the Microsoft 365 outage that began on November 12 until they have verified business-critical workflows, integrations and security controls. As of midday ET on November 13, according to the firm's research note, Microsoft had given no restoration time, so the outage had run into a second calendar day.